Alkermes Medicines & Focus: Cancer

We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new treatment options.

Videos from this campaign

Content from this campaign

Health & Healthcare

Alkermes Educates on the Challenges of Mucosal Melanoma
Did you know that that there is a type of melanoma that is not visible on skin? Watch this video to learn about mucosal melanoma including treatment challenges, and unmet needs.

Health & Healthcare

Alkermes Highlights Ongoing Investigational Immuno-oncology Clinical Trials
Alkermes is committed to researching and developing potential new cancer treatment options that may help address unmet patient needs.

Health & Healthcare

Alkermes Spotlights Cancer Research
While coping with the effects of cancer during the holidays is difficult, we find hope in the research work being done at Alkermes to help expand the future of cancer treatment for patients and their families.

Health & Healthcare

Alkermes Celebrates National Family Caregivers Month
November is National Family Caregivers Month and as we prepare for Thanksgiving, it is a perfect opportunity to express our sincerest gratitude to family caregivers.

Responsible Business & Employee Engagement

Alkermes Associate Director Discusses How Her Personal Journey With Ovarian Cancer Influences Her Work
During Ovarian Cancer Awareness Month, Alkermes employee, Kate, shares a glimpse into her personal journey with ovarian cancer, which inspires her work within the oncology space.

Health & Healthcare

Wellness Tips for Cancer Patients
The cancer experience can be highly emotional. However, prioritizing self-care may help cancer patients cope throughout their journeys.

Health & Healthcare

Alkermes Shares Immuno Oncology Clinical Trial Research
We are pleased to share clinical trial data on our investigational #immunooncology therapy and are excited to be a part of the 17th EADO Congress and 2021 World Mobile Congress Interactive Virtual Meeting.

Responsible Business & Employee Engagement

Alkermes Employee Reflects on His Family's Experience with Cancer and How It Impacts His Work
This Head and Neck Cancer Awareness Month, Peter, an Alkermes employee, shares his personal connection to this type of #cancer and the immense impact it has had on an important person in his life.

Health & Healthcare

Alkermes Celebrates National Cancer Control Month
April is National Cancer Control Month. At Alkermes, we are investigating new treatment options for cancer patients and raising awareness for cancer prevention.

Diversity & Inclusion

Alkermes Celebrates Female Oncology Pioneer in Honor of Women’s History Month
During Womens History Month we honor Dr. Mary-Claire King, who forever changed oncology by discovering mutations to BRCA could cause genetically inherited breast cancer.
Alkermes logo

More from Alkermes

  1. Alkermes: Diversity, Inclusion & Belonging
    Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that...
  2. Alkermes: Corporate Responsibility
    We strive to have a positive impact on our employees, members of our communities, our local environment and society at large. We support research...
  3. Alkermes Medicines & Focus: Serious Mental Illness
    We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with...
  4. Alkermes Medicines & Focus: Cancer
    We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new...
  5. Alkermes Inspiration Grants®
    Since 2016, the Alkermes Inspiration Grants® program has awarded more than $4 million in funding to innovative programs that support the comprehensive...
  6. Alkermes Medicines & Focus: Addiction
    We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid...